A PYMNTS Company

EU: General Electric gains from Thermer Fisher concessions

By  |  January 6, 2014

While the European Commission eventually cleared scientific technology firm Thermo Fisher’s buyout of Life Technologies last November, the regulator required concessions from the deal, ones that have been announced this week.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say Thermo Fisher has formally agreed to sell three of its units to General Electric’s healthcare business, a deal amounting to $1.06 billion. GE will acquire the cell culture, gene modulation and magnetic beads businesses, according to reports.

    Thermo Fisher said it is not anticipating any more forced sell-offs following its merger.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.